In the GEA criteria, indeed, HER2 positive tumors are those possessing an IHC score of 3+ in more than 10% of tumor cells or an IHC score of 2+ in more than 10% of tumor cells with confirmed HER2 gene amplification by FISH. Here, ERBB2 is linked to neoplasm.